Anal Cancer Therapeutics Market Analysis Devices, By Top Key Players, Global Industry Size 2025

Leading Market Manufacturers

Amgen Inc. (US), Bristol-Myers Squibb Company (US), Celgene Corporation (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck & Co., Inc. (US ), Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Sanofi (France), Johnson & Johnson Services, Inc. (US) and Hospira, Inc. (US)

Global Anal Cancer Market share Research Report: Information by Cancer Type (Carcinoma in Situ, Squamous Cell Carcinoma, Adenocarcinoma, Basal Cell Carcinoma, Melanoma and others), Treatment Type (Chemotherapy, Surgery, Radiation Therapy and Immunotherapy), End User (Hospitals & Clinics, Research & Academic Institutes and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025, Confirms MRFR

Anal Cancer Market Overview

Anal cancer is cancer of the anus or the surrounding area. Anal cancer can be caused by all of the regular causes of cancer, ie smoking, chewing tobacco, radiation poisoning, etc., but can also be caused by the HPV virus. In fact, HPV accounts for more than 90% of all anal cancers, making it a closely associated pathogen. Anal cancer is rarely found in younger demographics, with people above 60 being the prime candidate for the disease. It is estimated to cause more than 8,000 new cases in the US in 2019, accompanied by more than a thousand deaths. The five-year survival rate for anal cancer is 66%, a considerable improvement upon some other types of cancer but worrying nevertheless.

Segmentation:

Global anal cancer market has been segmented on the basis of type into squamous cell carcinoma, adenocarcinoma, perianal skin cancer, melanoma, and others.

On the basis of treatment, the global anal cancer market is segmented into chemotherapy, radio therapy, surgery, and others.

On the basis of end user, the global anal cancer market is segmented into hospitals, clinics, research institutes, and others.

Key Questions Answered in This Report:

  • What will the market size and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

 

Access the complete report @ https://www.marketresearchfuture.com/reports/anal-cancer-market-1530

Industry / Innovation / Related News:

November 30, 2018 - A research group at the University of Alabama (US), published their findings of the study they carried out for the treatments and vaccinations that can be repurposed for HPVs. Preclinical experiments indicated towards the cancer drugs vorinostat, belinostat and panobinostat that can be repurposed to treat infections caused by human papillomaviruses, or HPV.

Related News

Global Rheumatoid arthritis Market Research Report- Forecast To 2022

 

Global Perfusion Imaging Market Research Report Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR ), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Root Canal Market share Valuation, Trends and Forecast to 2027

  The Global Root Canal Market could touch the valuation of USD 21.0 billion by 2023, asserts Market Research Future (MRFR). It is expected to achieve a CAGR of 8.0 % during the forecast period (2017-2023). Growth Drivers and Key Barriers The global root canal market benefits from the rising demand for the treatment owing to the expanding population and the subsequent surge in the number of procedures performed. The boost in number of screenings, greater stress on restorative dental procedures, greater consumption of starch-rich diets and fast foods and rising efficacy, efficiency and success rate of root canal treatment has taken the market to greater heights.  Having said that, the high cost of root canal treatment could act as a barrier for the market in the near future. However, as product development is one of the best strategies for market growth, the market could observe exponential growth in the coming years. This factor stands true on the back of technological advancements
Read more

Cardiovascular Ultrasound Market,Growth, Demand and Key Players to 2027

  GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Cardiovascular Ultrasound Market and are profiled in MRFR Analysis.  Global Cardiovascular Ultrasound  Market - Overview Cardiovascular ultrasound imaging system market has increased due to increase in the incidence of cardiovascular diseases, changing lifestyle of people, increase in incidence of diabetes and other risk factors favouring the growth of this market. Increase in demand of cardiovascular ultrasound imaging system in hospitals for diagnosis of heart disease or before any surgical procedure favour the growth of this market.     Cardiovascular diseases gain a huge attention due to increasing prevalence. Due to increasing number of death from cardiovascular diseases, number of companies are in a race for the introduction of th
Read more

Root Canal Market Leading Players, Sales Projection and COVID-19 Impact Analysis By 2027

  Market Scenario A root canal is a dental procedure involving the removal of the central pulp from the tooth. A root canal is performed when the pulp of a tooth is injured, inflamed or infected. The objective of the root canal is to save the structure of the tooth and to prevent infection of the gums and other teeth. Common causes of the root canal treatment include deep decay due to the cavity, a chip or crack in the tooth, an injury to the tooth, infection, and others. The most common symptoms of damaged pulp include pain, swelling, and a heat sensation in the gums. also read @  http://www.marketwatch.com/story/root-canal-market-trends-size-share-demand-forecast-business-revenue-investment-opportunities-competitor-strategies-and-impact-of-covid-19-2021-01-17 Growth Drivers and Key Barriers The global root canal market benefits from the rising demand for the treatment owing to the expanding population and the subsequent surge in the number of procedures performed. The boost in nu
Read more